| 000 | 01394 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516133358.0 | ||
| 264 | 0 | _c20130402 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/cei.12023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIwamoto, S | |
| 245 | 0 | 0 |
_aEfficacy of azithromycin in preventing lethal graft-versus-host disease. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cMar 2013 |
||
| 300 |
_a338-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAzithromycin _xpharmacology |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xprevention & control |
| 650 | 0 | 4 |
_aInterleukin-10 _xbiosynthesis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 700 | 1 | _aAzuma, E | |
| 700 | 1 | _aKumamoto, T | |
| 700 | 1 | _aHirayama, M | |
| 700 | 1 | _aYoshida, T | |
| 700 | 1 | _aIto, M | |
| 700 | 1 | _aAmano, K | |
| 700 | 1 | _aIdo, M | |
| 700 | 1 | _aKomada, Y | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 171 _gno. 3 _gp. 338-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.12023 _zAvailable from publisher's website |
| 999 |
_c22475656 _d22475656 |
||